CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in incidence of target diseases
4.1.2. Growing usage of home-based POC devices
4.1.3. Technological advancements and new product launches
4.1.4. Rise in infectious diseases in developing countries
4.2. Market Restraints & Challenges
4.2.1. The high cost of devices
4.2.2. Lack of knowledge on the usage on POC devices
4.3.3. Stringent and time-consuming policies
4.3. Market Opportunities
4.3.1. The rise in emerging markets
4.3.2. Increase in POC tests with multiplexing capabilities
CHAPTER 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PLATFORM
5.1 Introduction
5.2 Molecular Diagnostics
5.3 Dipsticks
5.4 Microfluidics
5.5 Lateral Flow Assays
5.6 Immunoassays
CHAPTER 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY PRODUCT
6.1. Introduction
6.2. Tumour/Cancer Marker Testing Products
6.3. Urinalysis Testing Products
6.4. Cholesterol Testing Products
6.5. Haematology Testing Products
6.6. Drugs-of-Abuse Testing Products
6.7. Faecal Occult Testing Products
6.8. Other POC Products
6.9. Cardiometabolic Testing Products
6.9.1 Cardiac Marker Testing Products
6.9.2 Blood Gas/Electrolytes Testing Products
6.9.3 HBA1C Testing Products
6.10. Glucose Monitoring Products
6.10.1 Strips
6.10.2 Meters
6.10.3 Lancets & Lancing Devices
6.11. Infectious Disease Testing Products
6.11.1. Influenza Testing Products
6.11.2. HIV Testing Products
6.11.3. Hepatitis C Testing Products
6.11.4. Sexually Transmitted Disease (STD) Testing Products
6.11.5. Healthcare-Associated Infection (HAI) Testing Products
6.11.6. Respiratory Infection Testing Products
6.11.7. Tropical Disease Testing Products
6.11.8. Other Infectious Disease Testing Products
6.12. Coagulation Testing Products
6.12.1.PT/INR Testing Products
6.12.2. Activated Clotting Time (ACT/APTT) Testing Products
6.13. Pregnancy and Fertility Testing Products
6.13.1. Pregnancy Testing Products
6.13.2. Fertility Testing Products
CHAPTER 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PRESCRIPTION MODE
7.1 Introduction
7.2 Prescription-Based Testing
7.3 OTC Testing
CHAPTER 8. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY END USER
8.1. Introduction
8.2. Professional Diagnostic Centers
8.2.1. Outpatient Healthcare & Ambulatory Care Settings
8.2.2. Hospitals/Critical Care Centers
8.3. Home Care
8.4. Research Laboratories
8.5. Other End Users
CHAPTER 9. GLOBAL POINT OF CARE DIAGNOSTICS MARKET- BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL POINT OF CARE DIAGNOSTICS MARKET- COMPANY
PROFILES
10.1. Trinity Biotech
10.2. PTS Diagnostics
10.3. Becton, Dickinson, and Company (BD)
10.4. Chembio Diagnostics
10.5. Quidel Corporation
10.6. EKF Diagnostics
10.7. Abbott Laboratories
10.8. Johnson & Johnson
10.9. Nova Biomedical
10.10. Instrumentation Laboratory
10.11. Danaher Corporation
10.12. Roche Diagnostics
10.13. Sekisui Diagnostics
10.14. Siemens
10.15. AccuBiotech Co., Ltd.
CHAPTER 11. GLOBAL POINT OF CARE DIAGNOSTICS MARKET-
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures